Observational studyBlood advances2025

Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study.

Ofir Wolach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.